What is Crescent Biopharma, Inc.'s share price today?
Crescent Biopharma, Inc. (CBIO) share price today is $13.57 as of November 5, 2026 at 1:21 AM IST. The stock touched a day high of $14.06 and a day low of $13.27.What exchange does Crescent Biopharma, Inc. stock trade on, and under what ticker symbol?
Crescent Biopharma, Inc. stock trades on NASDAQ under the ticker symbol CBIO.What is Crescent Biopharma, Inc.'s market capitalization?
Crescent Biopharma, Inc.'s market capitalization is $479.56M as of November 5, 2026 at 1:21 AM IST.What is Crescent Biopharma, Inc.'s price-to-earnings (P/E) ratio?
Crescent Biopharma, Inc.'s price-to-earnings (P/E) ratio is N/A as of November 4, 2026.What is Crescent Biopharma, Inc.'s price-to-book (P/B) ratio?
Crescent Biopharma, Inc.'s price-to-book (P/B) ratio is 3.14 as of November 4, 2026.Can Indian investors buy Crescent Biopharma, Inc. shares?
Yes, You can buy Crescent Biopharma, Inc. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Crescent Biopharma, Inc. shares from India?
Indian investors can buy Crescent Biopharma, Inc. shares in three steps: 1. Search Crescent Biopharma, Inc. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Crescent Biopharma, Inc. shares for Indian investors?
Since Crescent Biopharma, Inc. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Crescent Biopharma, Inc. shares via Tickertape?
Indian investors can start investing in Crescent Biopharma, Inc. (CBIO) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.7369 shares at the current price of $13.57.
Key Metrics
Key Metrics
Close price divided by the earnings per share for the trailing twelve months
Close price divided by the book value per share at the end of the most recent quarter
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
Net profit divided by the total revenue for the most recent financial year
Annual dividend per share for the trailing twelve months divided by the close price
Based on 8 analysts reports
Price Upside
+144%
Earnings Growth
+91.44%
Rev. Growth
-84.09%
Company Profile
Company Profile
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
All values in $
All values in $
Revenue Forecast
Revenue Forecast
All values in $ Million
All values in $ Million
Earnings Per Share Forecast
Earnings Per Share Forecast
All values in $
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | - | - | - | 0 | 0 | 0 | 30.56 | 10.84 | 1.03 | 0 |
| Gross Profit | -0.01 | -0.01 | -0 | 0.02 | - | -0 | 28.93 | 10.84 | 1.03 | - |
| Net Income | -10.73 | -10.09 | -9.82 | -17.86 | -15.14 | -21.79 | -24.60 | -92.39 | -23.28 | -22.68 |
| Net Profit Margin | - | - | - | - | - | - | -80.50% | -852.05% | -2240.90% | - |
Peers
Peers & Comparison
Peers & Comparison
HealthcareBiotechnology
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Crescent Biopharma, Inc. | - | 3.14 | - |
| AbbVie Inc | 50.67 | 50.45 | 0.60 |
| Amgen Inc | 28.90 | 21.55 | 2.77 |
The 12-month consensus target implies 144.00% growth, versus a trailing 3-year CAGR of -54.27%.